Compare · CEPL vs TMO

CEPL vs TMO

Side-by-side comparison of Capstone Energy Plus Inc. (CEPL) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CEPL and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
  • TMO is the larger of the two at $257.42B, about 2694.0x CEPL ($95.6M).
  • Over the past year, CEPL is down 74.8% and TMO is up 20.6% - TMO leads by 95.4 points.
  • TMO has been more active in the news (9 items in the past 4 weeks vs 2 for CEPL).
  • TMO has more recent analyst coverage (25 ratings vs 0 for CEPL).
PerformanceCEPL-74.80%TMO+36.29%
2026-07-08+0.00%2026-11-06
MetricCEPLTMO
Company
Capstone Energy Plus Inc.
Thermo Fisher Scientific Inc
Price
-
-
Market cap
$95.6M
$257.42B
1M return
-30.07%
+6.62%
1Y return
-74.80%
+20.60%
Industry
Industrial Machinery/Components
Industrial Machinery/Components
Exchange
NASDAQ
NYSE
IPO
News (4w)
2
9
Recent ratings
0
25
CEPL

Capstone Energy Plus Inc.

For nearly four decades, Capstone Energy+ has designed, developed, and delivered proven on-site energy solutions that help businesses operate with certainty in an increasingly constrained power environment. Our evolution from 'Green' to 'Plus' reflects who we are today, delivering clean, innovative energy solutions that go beyond electricity. With more than 10,800 units shipped across 89 countries through our global distributor network, Capstone provides highly reliable, low-maintenance, fuel-flexible power systems engineered for mission-critical operations. Built on our core 30kW, 65kW, and 200kW gas turbine platforms, our scalable multi-megawatt solutions are designed for rapid deployment, continuous operation, and simplified maintenance. Capstone Energy+ serves critical industries including data centers, hospitals, agriculture, and industrial facilities where uptime and energy certainty are essential.

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.